Detalhe da pesquisa
1.
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Lancet Oncol
; 25(2): 175-183, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218192
2.
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
; 51(8): 2428-2441, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528164
3.
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
; 51(1): 183-195, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37721581
4.
Potential utility of B-type natriuretic peptides in secondary prevention following percutaneous coronary intervention in remote communities of Western Australia.
Biomarkers
; 28(5): 458-465, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37128799
5.
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes.
Mol Diagn Ther
; 28(3): 291-299, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446353
6.
Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen in Heavily Pre-Treated Patients.
Diagnostics (Basel)
; 11(3)2021 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799431
7.
Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer.
World J Nucl Med
; 18(3): 232-237, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31516365
8.
Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
J Alzheimers Dis
; 13(2): 137-46, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18376055
9.
Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.
Diagnostics (Basel)
; 8(1)2018 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439481
10.
Salvage Radiopeptide Therapy of Advanced Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen: Efficacy and Safety in Routine Practice.
Cancer Biother Radiopharm
; 33(7): 274-281, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29989440
11.
The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer.
Nucl Med Commun
; 38(11): 956-963, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28922335
12.
Epidemiology of ductal carcinoma in situ in Western Australia: implications for surgical margins and management.
Breast Cancer
; 22(6): 641-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777718
13.
Pseudolymphoma syndrome: findings on a gallium-67 citrate scan.
Clin Nucl Med
; 31(1): 16-7, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16374115
14.
New lexicon and criteria for the diagnosis of Alzheimer's disease.
Lancet Neurol
; 10(4): 299-300; author reply 300-1, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21435594
15.
Ectopic parathyroid adenoma localised with sestamibi SPECT and image-fused computed tomography.
Med J Aust
; 179(9): 485-7, 2003 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-14583080
16.
The Australian government's review of positron emission tomography: evidence-based policy decision-making in action.
Med J Aust
; 181(9): 516-7; author reply 517-8, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15516203
17.
Diffuse splenic metastases from seminoma visualized on FDG PET.
AJR Am J Roentgenol
; 183(2): 525-7, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15269051